Disseminated
COVID-19
Corticosteroids
Cryptococcus neoformans
Journal
Medical mycology case reports
ISSN: 2211-7539
Titre abrégé: Med Mycol Case Rep
Pays: Netherlands
ID NLM: 101598259
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
11
06
2021
revised:
24
09
2021
accepted:
11
10
2021
pubmed:
28
10
2021
medline:
28
10
2021
entrez:
27
10
2021
Statut:
ppublish
Résumé
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus associated with immune dysregulation. The use of immunosuppressant drugs as part of COVID-19 treatment (such as Tocilizumab or high -dose corticosteroids) increases the risk of opportunistic infections. Here we present a case of a patient without prior immunosuppression that developed a serious fungal infection after the use of high dose corticosteroids in the setting of severe COVID-19 and cryptogenic organizing pneumonia.
Identifiants
pubmed: 34703755
doi: 10.1016/j.mmcr.2021.10.001
pii: S2211-7539(21)00052-X
pmc: PMC8531235
doi:
Types de publication
Case Reports
Langues
eng
Pagination
35-37Informations de copyright
© 2021 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.
Références
Discoveries (Craiova). 2021 Mar 31;9(1):e126
pubmed: 34036149
J Hosp Infect. 2021 Jul;113:115-129
pubmed: 33891985
QJM. 2002 Aug;95(8):511-8
pubmed: 12145390
Int J STD AIDS. 2011 Nov;22(11):665-70
pubmed: 22096053
Mycopathologia. 2020 Aug;185(4):607-611
pubmed: 32737746
Clin Case Rep. 2020 Dec 19;9(2):853-855
pubmed: 33598258
SN Compr Clin Med. 2020 Oct 8;:1-5
pubmed: 33047097
Biologia (Bratisl). 2021 Jun 2;:1-19
pubmed: 34092799
BMC Infect Dis. 2020 Aug 5;20(1):571
pubmed: 32758162